Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Laboratory tests are crucial for safer and more effective aesthetic procedures.

Reconstructed skin models are useful for studying how skin processes certain chemicals.

A new method accurately measures clobetasol propionate in hair and skin.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Gene editing holds promise for skin treatments but needs careful safety and ethical consideration.

SNP profiling allows personalized skincare treatments for better results and fewer side effects.

Dermatologists should focus on restoring skin health and well-being in cancer survivors.

Nanoparticles improve skin treatment but need more research on safety and effectiveness.

Vitiligo treatments are improving but relapses are common.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Non-invasive methods can effectively monitor skin inflammation and cancer biomarkers.

Complementary and alternative medicines show promise in dermatology, but more research is needed.

Some cosmetic ingredients can harm health, causing issues like allergies, cancer, and skin problems.

Antiseptic particles penetrate deeper into hair follicles than non-antiseptic ones.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Different types of skin on mice have unique chemical profiles related to how they grow and react to stress.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Quasi-drugs in Japan and South Korea are regulated to ensure safety and effectiveness, offering products with mild therapeutic effects.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Customized dermatological treatments effectively address gaps in standard products, especially for complex cases.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.